Insider Transactions in Q2 2019 at Humanigen, Inc (HGEN)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2019
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+1.42%
|
$8,000
$1.25 P/Share
|
|
May 31
2019
|
Dale Chappell Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Indirect |
1,177,275
+1.22%
|
-
|
|
May 31
2019
|
Cameron Durrant Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
235,624
+30.02%
|
-
|
|
May 31
2019
|
Ronald Barliant |
BUY
Other acquisition or disposition
|
Direct |
236,499
+36.77%
|
-
|
|
May 29
2019
|
Rainer J. Boehm |
BUY
Grant, award, or other acquisition
|
Direct |
238,625
+42.93%
|
$0
$0.66 P/Share
|
|
May 14
2019
|
Robert G. Savage |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+33.35%
|
$0
$0.66 P/Share
|
|
Apr 23
2019
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+19.3%
|
$0
$0.66 P/Share
|